Shree Hari Chemicals Export Ltd: Valuation Upgrade Signals Renewed Price Attractiveness

Valuation Metrics Reflect Growing Appeal

As of 5 August 2026, Shree Hari Chemicals Export Ltd trades at ₹141.75, up 5.78% from the previous close of ₹134.00. The stock is nearing its 52-week high of ₹146.70, having rebounded strongly from a low of ₹87.65. This price appreciation is underpinned by a recalibration of key valuation ratios that have shifted the company’s grade from very attractive to attractive.

The current P/E ratio stands at 21.70, a level that is moderate within the commodity chemicals sector but significantly more appealing than many peers. For context, J.G. Chemicals trades at a P/E of 30.1, while Titan Biotech is priced at a steep 57.17. Even more expensive peers such as Indo Borax & Chemicals and Oriental Aromatics exhibit P/E ratios exceeding 30 and 240 respectively, underscoring Shree Hari Chemicals’ relative valuation advantage.

Similarly, the price-to-book value ratio of 2.02 indicates a reasonable premium over book value, reflecting investor confidence without excessive exuberance. This contrasts with some sector players whose P/BV ratios are inflated by market speculation or growth expectations.

Comparative Enterprise Value Multiples

Enterprise value (EV) multiples further illustrate the company’s valuation standing. Shree Hari Chemicals’ EV to EBITDA ratio is 17.45, which, while higher than some peers like DCW at 6.6, remains below the very expensive Titan Biotech at 44.34. The EV to EBIT ratio of 27.13 also suggests a balanced valuation, neither undervalued nor excessively stretched.

These multiples indicate that the market is recognising the company’s operational earnings potential, albeit with cautious optimism given the sector’s cyclical nature and the company’s micro-cap status.

Financial Performance and Returns Contextualise Valuation

Shree Hari Chemicals’ return metrics reinforce the valuation upgrade. The company has delivered a 5.00% return over the past week and an impressive 28.86% return over the last month, significantly outperforming the Sensex’s 2.17% and 0.86% respective returns. Year-to-date, the stock has gained 8.21%, while the Sensex has declined 7.97%, highlighting the stock’s resilience amid broader market weakness.

Longer-term returns are even more compelling, with a three-year return of 201.60% dwarfing the Sensex’s 19.34% gain. Over five years, the stock has nearly doubled with a 99.65% return, compared to the Sensex’s 44.25%. These figures suggest that the market is rewarding Shree Hari Chemicals for sustained growth and operational improvements.

Quality Metrics and Operational Efficiency

Despite the valuation improvement, Shree Hari Chemicals’ return on capital employed (ROCE) and return on equity (ROE) remain modest at 6.07% and 9.30% respectively. These figures suggest room for operational enhancement and margin expansion to justify higher valuation multiples sustainably.

The company’s PEG ratio is currently 0.00, which may indicate either a lack of earnings growth projection or data unavailability. This contrasts with peers like J.G. Chemicals, which has a PEG of 10.48, and Titan Biotech at 1.48, reflecting varying growth expectations within the sector.

Micro-Cap Status and Market Capitalisation

Shree Hari Chemicals remains classified as a micro-cap stock, which inherently carries higher volatility and risk. However, the recent upgrade in Mojo Grade from Sell to Hold on 4 August 2026, with a current Mojo Score of 51.0, reflects a cautious but positive reassessment of the company’s prospects by market analysts.

The stock’s recent price momentum and valuation attractiveness relative to peers may attract increased institutional and retail interest, potentially supporting further price appreciation.

Sector and Peer Comparison

Within the commodity chemicals sector, valuation disparities are pronounced. While Shree Hari Chemicals is rated attractive, several peers are classified as expensive or very expensive, including I G Petrochemicals with a staggering P/E of 695.03 and Oriental Aromatics at 241.65. This valuation dispersion highlights the selective nature of investor capital allocation in the sector, favouring companies with clearer growth visibility or operational stability.

Conversely, some companies like TGV Sraac are deemed very attractive with a P/E of 8.67, indicating potential undervaluation or differing business fundamentals. Investors should weigh these factors carefully when considering exposure to the sector.

Investor Takeaway

The upgrade in valuation grade from very attractive to attractive, coupled with a Mojo Grade improvement to Hold, signals a turning point for Shree Hari Chemicals Export Ltd. The stock’s valuation metrics now present a more balanced risk-reward profile compared to its historical positioning and peer group.

However, investors should remain mindful of the company’s modest profitability ratios and micro-cap status, which can entail higher volatility. The stock’s recent outperformance relative to the Sensex and sector peers is encouraging, but sustained operational improvements will be critical to justify further multiple expansion.

For those seeking exposure to the commodity chemicals sector, Shree Hari Chemicals offers a compelling case for inclusion in a diversified portfolio, particularly given its attractive valuation relative to many expensive peers. Nonetheless, ongoing monitoring of earnings growth, margin trends, and sector dynamics is advisable.

Conclusion

Shree Hari Chemicals Export Ltd’s valuation upgrade reflects a market reassessment of its price attractiveness amid improving stock performance and relative sector positioning. While the company’s financial metrics suggest cautious optimism, the stock’s recent momentum and comparative valuation advantage make it a noteworthy candidate for investors seeking micro-cap opportunities in the commodity chemicals space.

As always, a balanced approach considering both valuation and quality metrics will serve investors best in navigating this evolving investment landscape.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →